Cenobamate is a medicine used to treat seizures that start in one part of the brain (focal or partial-onset seizures) in adults. It is taken as a pill once a day. It works by calming overactive nerve signals in the brain.
Every report comes from a Lived member, sent anonymously.
Have you tried Xcopri (Cenobamate) for Focal Epilepsy?
Cenobamate, sold as Xcopri, is a prescription antiseizure medicine for adults with partial-onset seizures, also called focal seizures. These are seizures that begin in one area of the brain. Some stay limited to that area, causing symptoms such as staring, twitching or unusual sensations, while others spread and become a convulsive seizure. Cenobamate can be used on its own or added to other seizure medicines. In practice it is most often added when seizures continue despite one or more other medicines, which is the group it was tested in. It is not approved for children, because its safety and effectiveness under 18 have not been established.
Seizures happen when groups of nerve cells in the brain fire in rapid, uncontrolled bursts. Cenobamate works on two of the brain's controls over that firing. It blocks sodium channels, the tiny gates that let nerve cells fire repeatedly, and it strengthens the effect of GABA (gamma-aminobutyric acid), the brain's main calming chemical messenger. Together these make it harder for a burst of abnormal activity to start or spread. Exactly how this produces its benefit in epilepsy is not fully understood.
Cenobamate is a tablet taken once a day, at any time, with or without food. Treatment starts at a very low dose, 12.5 mg, and goes up in steps every two weeks. Most people reach the usual maintenance dose of 200 mg after about 11 weeks. The prescriber may raise it further, up to 400 mg, if seizures continue and side effects allow. Titration packs supply the lower-strength tablets used during the build-up. The slow build-up is a safety step, not just a way to ease side effects. A rare but serious allergic reaction happened in early studies when the dose was raised faster, so the schedule should not be sped up. Tablets can be swallowed whole or crushed and mixed with water to drink right away or give through a feeding tube. Liver problems change the safe maximum dose, and a kidney problem may call for a lower one. Do not stop cenobamate suddenly. Stopping abruptly can trigger more seizures, including a prolonged seizure that does not stop on its own (status epilepticus). When it is stopped, the dose is lowered gradually over at least two weeks.
The most common side effects are sleepiness, tiredness, dizziness, double vision and headache. Unsteady walking, poor coordination and slowed thinking or trouble concentrating can also occur. These effects increase with dose, are most likely during the early weeks and after dose increases, and are a common reason doses are adjusted. A rare, serious allergic reaction called DRESS (drug reaction with eosinophilia and systemic symptoms) can affect the skin and internal organs such as the liver, kidneys or blood cells. It may begin with fever, swollen glands or sores in the mouth, sometimes without any rash. Fever, rash, swollen glands, swelling of the face, lips or tongue, or trouble swallowing or breathing while taking cenobamate need emergency medical care right away. Serious liver injury, including liver failure that required a transplant, has been reported since the drug came on the market. A liver blood test is done before starting if one has not been done in the last three months. Yellowing of the skin or eyes, dark urine, unexplained nausea or vomiting, pain in the upper right part of the belly or unusual tiredness should be reported to the prescriber right away. Hallucinations, paranoia or aggressive behavior have also been reported and should be reported promptly.
Cenobamate changes the levels of several other seizure medicines. It raises levels of phenytoin, phenobarbital and clobazam, which can increase their side effects, and lowers levels of lamotrigine and carbamazepine, which can make them less effective. The prescriber often adjusts these doses as cenobamate is increased. It can also affect many other medicines processed by the liver, so the prescriber and pharmacist should know about everything taken, including supplements. Cenobamate can make birth control pills less effective. People who could become pregnant should use an additional or a non-hormonal method, such as a copper intrauterine device (IUD) or condoms. Its effects in pregnancy are not known, and animal studies showed harm to developing offspring. Anyone who is pregnant or planning a pregnancy should discuss the balance of risks with the prescriber, since uncontrolled seizures also carry risks. A pregnancy registry tracks outcomes for people taking seizure medicines. Cenobamate shortens the QT interval, a measure of the heart's electrical cycle seen on an electrocardiogram (ECG), a heart tracing. People with familial short QT syndrome, an inherited heart rhythm condition, should not take it. Prolonged racing heartbeat or fainting should be reported to the prescriber. Like all antiseizure medicines, cenobamate carries an FDA warning about suicidal thoughts and behavior, estimated to affect about 1 in 500 people taking them. New or worsening depression, anxiety, agitation or thoughts of self-harm should be reported to the prescriber right away. Alcohol and other sedating medicines add to drowsiness and dizziness, and driving should wait until the person knows how the medicine affects them. Xcopri is a Schedule V controlled substance because high doses can produce a pleasurable effect in some people and the body can come to depend on it.
Because the dose rises slowly, the full effect usually is not judged until the maintenance dose is reached around three months in. In the main studies of adults whose seizures were not controlled by other medicines, the number of seizures fell by about half for a typical person on 200 mg a day, compared with about a fifth on a placebo (a dummy pill). Some people did better: about 1 in 5 on the highest dose had no focal seizures during the last three months of the study. Others saw little change. Follow-up visits focus on how often seizures occur, side effects and whether other seizure medicines need adjusting. Keeping a seizure diary helps show whether it is working. Cenobamate is usually a long-term treatment. If it helps, it is continued to keep seizures under control. If it does not help or is poorly tolerated, the prescriber can lower the dose or taper it off and try another option.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Xcopri (Cenobamate), what you've noticed, or ask the community a question.